<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<rss version="2.0">
  <channel>
    <title>Clinical Chemistry and Laboratory Medicine (CCLM)</title>
    <link>www.degruyter.com</link>
    <description/>
    <item>
      <title>Frontmatter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-frontmatter9/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-frontmatter9/html</guid>
    </item>
    <item>
      <title>Developments in reference measurement systems for C-reactive protein and the importance of maintaining currently used clinical decision-making criteria</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0558/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0558/html</guid>
    </item>
    <item>
      <title>Why C-reactive protein is one of the most requested tests in clinical laboratories?</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0086/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0086/html</guid>
    </item>
    <item>
      <title>C-reactive protein and clinical outcome in COVID-19 patients: the importance of harmonized measurements</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0276/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0276/html</guid>
    </item>
    <item>
      <title>Current performance of C-reactive protein determination and derivation of quality specifications for its measurement uncertainty</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0069/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0069/html</guid>
    </item>
    <item>
      <title>Implementing metrological traceability of C-reactive protein measurements: consensus summary from the Joint Committee for Traceability in Laboratory Medicine Workshop</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0498/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0498/html</guid>
    </item>
    <item>
      <title>Analytical performance specifications for the measurement uncertainty of 24,25-dihydroxyvitamin D examinations</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0176/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0176/html</guid>
    </item>
    <item>
      <title>A new door to a different world: opportunities from the metaverse and the raise of meta-medical laboratories</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0108/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0108/html</guid>
    </item>
    <item>
      <title>Point-of-care testing performed by healthcare professionals outside the hospital setting: consensus based recommendations from the IFCC Committee on Point-of-Care Testing (IFCC C-POCT)</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0502/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0502/html</guid>
    </item>
    <item>
      <title>Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer’s disease</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0245/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0245/html</guid>
    </item>
    <item>
      <title>Long-term stability of thyroid peroxidase antibody (anti-TPO) in serum in the Danish General Suburban Population Study</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-0845/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-0845/html</guid>
    </item>
    <item>
      <title>Exploration of suitable external quality assessment materials for serum C-peptide measurement</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0215/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0215/html</guid>
    </item>
    <item>
      <title>Description and validation of an equilibrium dialysis ID-LC-MS/MS candidate reference measurement procedure for free thyroxine in human serum</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1134/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1134/html</guid>
    </item>
    <item>
      <title>Evaluation of testosterone, estradiol and progesterone immunoassay calibrators by liquid chromatography mass spectrometry</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1179/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1179/html</guid>
    </item>
    <item>
      <title>Lack of comparability of immunoassays for rheumatoid factor isotypes</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0109/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0109/html</guid>
    </item>
    <item>
      <title>Validation of ELISA assays for the calculation of FLC indices for the diagnosis of intrathecal immunoglobulin synthesis</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-0602/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-0602/html</guid>
    </item>
    <item>
      <title>First-trimester screening for Down syndrome using quadruple maternal biochemical markers</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1305/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1305/html</guid>
    </item>
    <item>
      <title>Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditions</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0139/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0139/html</guid>
    </item>
    <item>
      <title>Interlaboratory variation for NT-proBNP among Swedish laboratories in an external quality program 2011–2021</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0051/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0051/html</guid>
    </item>
    <item>
      <title>SARS-CoV-2 specific T-cell humoral response assessment after COVID-19 vaccination using a rapid direct real-time PCR amplification</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0129/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0129/html</guid>
    </item>
    <item>
      <title>Efficiency evaluation of a SARS-CoV-2 diagnostic strategy combining high throughput quantitative antigen immunoassay and real time PCR</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0087/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0087/html</guid>
    </item>
    <item>
      <title>Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0134/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0134/html</guid>
    </item>
    <item>
      <title>Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1321/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2022-1321/html</guid>
    </item>
    <item>
      <title>Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0164/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0164/html</guid>
    </item>
    <item>
      <title>Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0226/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0226/html</guid>
    </item>
    <item>
      <title>Impact of switching total bilirubin assays on the classification of neonates at high risk for hyperbilirubinemia</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0111/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0111/html</guid>
    </item>
    <item>
      <title>Discrepancies in PSA values among laboratories: the case of a traveling patient</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0043/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0043/html</guid>
    </item>
    <item>
      <title>Measurement of amyloid-β 1–42 in cerebrospinal fluid: a comparison of the second generation Elecsys and INNOTEST</title>
      <link>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0191/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/cclm-2023-0191/html</guid>
    </item>
  </channel>
</rss>
